Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium, PEA, HMW Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth
NCT07305519Recruiting
- Sponsor
- Sapienza University of Rome
- Start
- Apr 2026
- Primary completion
- Apr 2027
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of magnesium, palmitoylethanolamide, high molecular weight hyaluronic acid, pyridoxine and vitamin d in preterm birth (2 arms), sponsored by Sapienza University of Rome. Primary endpoint: Preterm Birth before 37 weeks. Started Apr 2026; status: recruiting.
02
Drugs
magnesiumpalmitoylethanolamidehigh molecular weight hyaluronic acidpyridoxinevitamin d
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT07305519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07305519.